These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis. Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R Oncology; 2015; 88(4):226-33. PubMed ID: 25503195 [TBL] [Abstract][Full Text] [Related]
5. Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers. South SA; Vance H; Farrell C; DiCioccio RA; Fahey C; Piver MS; Rodabaugh KJ Cancer; 2009 Jan; 115(2):324-33. PubMed ID: 19117025 [TBL] [Abstract][Full Text] [Related]
6. Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care. Pokharel HP; Hacker NF; Andrews L Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):633-638. PubMed ID: 27530527 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer screening in BRCA and Lynch syndrome mutation carriers. Castro E; Goh CL; Eeles RA Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714454 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer. Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353 [TBL] [Abstract][Full Text] [Related]
9. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families. Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C; Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211 [TBL] [Abstract][Full Text] [Related]
10. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome. Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183 [TBL] [Abstract][Full Text] [Related]
11. Genetic testing by cancer site: ovary. Weissman SM; Weiss SM; Newlin AC Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606 [TBL] [Abstract][Full Text] [Related]
15. Cancer genetics and reproduction. Hanson H; Hodgson S Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):3-18. PubMed ID: 19864186 [TBL] [Abstract][Full Text] [Related]
16. Evidence for breast cancer as an integral part of Lynch syndrome. Buerki N; Gautier L; Kovac M; Marra G; Buser M; Mueller H; Heinimann K Genes Chromosomes Cancer; 2012 Jan; 51(1):83-91. PubMed ID: 22034109 [TBL] [Abstract][Full Text] [Related]
17. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. Boilesen AE; Bisgaard ML; Bernstein I Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272 [TBL] [Abstract][Full Text] [Related]
18. Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Jensen UB; Sunde L; Timshel S; Halvarsson B; Nissen A; Bernstein I; Nilbert M Breast Cancer Res Treat; 2010 Apr; 120(3):777-82. PubMed ID: 19575290 [TBL] [Abstract][Full Text] [Related]